Looking for BMS3031 - Molecular mechanisms of disease - S1 2026 test answers and solutions? Browse our comprehensive collection of verified answers for BMS3031 - Molecular mechanisms of disease - S1 2026 at learning.monash.edu.
Get instant access to accurate answers and detailed explanations for your course questions. Our community-driven platform helps students succeed!
A mutation is introduced into a signalling protein that prevents RAS from binding GTP while leaving its GDP-bound form intact. Cells expressing this mutant protein show dramatically reduced proliferation.
Which step in the activation of B-RAF is most directly disrupted?
A dermatology study compares mutation patterns across different skin cancers. One tumour type shows a very high mutation burden associated with UV exposure, frequent p53 disruption, and slow but persistent local growth rather than aggressive metastasis.
Which cancer type BEST fits this profile?